Induced pluripotent stem cell (iPSC)-derived therapies have opened up a new avenue for stem cell research and unique opportunities to shift cell therapy into an allogeneic paradigm. The development of these therapies requires high-quality iPSC banks generated via standardized workflows to minimize starting material bank-to-bank variability.
Two expert scientists will share their long-standing experience working with IPSCs, the associated challenges, and the workflow and protocol optimizations needed to achieve doses relevant for clinical studies or further manufacturing.
They will explain how to move from manual processes to a functionally closed, automated, and scalable system effectively using hollow-fiber perfusion technology to expand iPSCs.
In this webinar you will learn more about: